These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33107998)

  • 1. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
    Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB
    Am J Hematol; 2021 Feb; 96(2):199-207. PubMed ID: 33107998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment.
    Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB
    Am J Hematol; 2021 Feb; 96(2):188-198. PubMed ID: 33170956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh).
    Chakrabarti P; George B; Shanmukhaiah C; Sharma LM; Udupi S; Ghanima W
    J Patient Rep Outcomes; 2022 Mar; 6(1):24. PubMed ID: 35303181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A physician-patient survey for primary immune thrombocytopenia: Chinese subgroup analysis of I-WISh International Survey].
    Wang RT; Liu XG; Hou Y; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):369-375. PubMed ID: 34218578
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh).
    Eshghi P; Abolghasemi H; Akhlaghi AA; Ashrafi F; Bordbar M; Hajifathali A; Hosseini H; Mirbehbahani N; Abedini A; Shahsavarani N; Faranoush M
    Clin Appl Thromb Hemost; 2023; 29():10760296221130335. PubMed ID: 36630731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia.
    Viana R; D'Alessio D; Grant L; Cooper N; Arnold D; Morgan M; Provan D; Cuker A; Hill QA; Tomiyama Y; Ghanima W
    Adv Ther; 2021 Dec; 38(12):5791-5808. PubMed ID: 34704193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in adult primary immune thrombocytopenia.
    Sestøl HG; Trangbæk SM; Bussel JB; Frederiksen H
    Expert Rev Hematol; 2018 Dec; 11(12):975-985. PubMed ID: 30444433
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of ITP on physician visits and workplace productivity.
    Tarantino MD; Mathias SD; Snyder CF; Isitt JJ; Gernsheimer T; Young J
    Curr Med Res Opin; 2010 Feb; 26(2):319-28. PubMed ID: 19968458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.
    Rüfer A; Terrell DR
    Br J Haematol; 2023 Oct; 203(1):79-85. PubMed ID: 37735553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China.
    Zhang W; Xie S; Fu R; Chen Y; Liu W; Sun T; Ju M; Li H; Xue F; Zhang L; Liu X; Yang R
    Expert Rev Hematol; 2023; 16(12):1125-1133. PubMed ID: 38009277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in children and adolescents with immune thrombocytopenia.
    Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
    Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology.
    Al-Samkari H; Cronin A; Arnold DM; Rodeghiero F; Grace RF
    J Thromb Haemost; 2021 Sep; 19(9):2348-2354. PubMed ID: 33974336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
    Flores A; Klaassen RJ; Buchanan GR; Neunert CE
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
    Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
    J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life.
    Maitland H; Lambert C; Ghanima W
    Hematology; 2024 Dec; 29(1):2375177. PubMed ID: 38975804
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
    Tamary H; Roganovic J; Chitlur M; Nugent DJ
    Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.
    Page LK; Psaila B; Provan D; Michael Hamilton J; Jenkins JM; Elish AS; Lesser ML; Bussel JB
    Br J Haematol; 2007 Jul; 138(2):245-8. PubMed ID: 17542983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI).
    Cooper N; Cuker A; Bonner N; Ghanima W; Provan D; Morgan M; Taylor B; D'Alessio D; Arnold D; Viana R
    Br J Haematol; 2021 Aug; 194(4):759-766. PubMed ID: 34263940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    Rovó A; Cantoni N; Samii K; Rüfer A; Koenen G; Ivic S; Cavanna D; Benz R
    PLoS One; 2022; 17(4):e0267342. PubMed ID: 35446925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in children with chronic immune thrombocytopenia in China.
    Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
    Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.